{"product_id":"ascendishealth-pestle-analysis","title":"Ascendis Health PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePlan Smarter. Present Sharper. Compete Stronger.\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eOur PESTLE Analysis for Ascendis Health pinpoints the political, economic, social, technological, legal, and environmental forces shaping its outlook—helping investors and strategists anticipate risks and opportunities; purchase the full report to access detailed drivers, scenarios, and actionable recommendations tailored to boardroom and investment decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSouth African Healthcare Policy Reform\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe phased rollout of South Africa’s National Health Insurance shifts procurement toward centralized, value-based purchasing; public healthcare expenditure rose to about ZAR 263 billion in 2023, increasing emphasis on cost containment and generics. Ascendis Health faces pressure on contract stability as 2024 pilot NHI procurement pilots report larger tender volumes but tighter margins, forcing repricing and longer receivable cycles for suppliers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeopolitical Stability in Export Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cppolitical instability across african markets risks disrupting ascendis healths supply chains and contributed to a year-on-year volatility in export volumes sub-saharan africa impacting distribution timelines working capital needs.\u003e\n\u003cptrade agreements and diplomatic ties south africas sacu african continental free trade area frameworks tariff exposure customs delays with non-tariff barriers linked to a increase in cross-border clearance times\u003e\n\u003cpcontinuous monitoring of regional conflicts and emergent trade restrictions is essential to protect consistent export revenue given that exports comprised roughly ascendis healths fy2024 are sensitive border disruptions.\u003e\n\u003c\/pcontinuous\u003e\u003c\/ptrade\u003e\u003c\/ppolitical\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment Regulatory Oversight\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSAHPRA enforces stringent product registration and safety standards, with South Africa recording a 12% increase in regulatory inspections in 2024, affecting time-to-market for Ascendis Health’s pipeline products.\u003c\/p\u003e\n\u003cp\u003ePolitical pressure to fast-track approvals during public health crises—seen in the 2023 COVID\/post-COVID emergency authorizations—can compress typical 18–24 month approval windows, altering launch timelines and revenue forecasts.\u003c\/p\u003e\n\u003cp\u003eFrequent shifts in bureaucratic leadership require Ascendis Health to maintain active regulatory affairs engagement; delays linked to leadership turnover have historically added 3–6 months to approval processes, impacting cash-flow planning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic Sector Procurement Dynamics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eState-led tenders account for roughly 30-40% of market opportunity for South African healthcare manufacturers; Ascendis Health’s public-sector sales could swing materially with tender allocations worth hundreds of millions ZAR annually.\u003c\/p\u003e\n\u003cp\u003ePolitical shifts may tighten B-BBEE rules for government contracts; amendments in 2024 increased minimum scorecard thresholds for preferential procurement, impacting bidder eligibility and contract value.\u003c\/p\u003e\n\u003cp\u003eContinuous compliance—including ownership, management control and procurement spend—remains essential for Ascendis to stay competitive in public health tenders and protect revenue streams.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePublic tenders ≈30–40% revenue exposure\u003c\/li\u003e\n\u003cli\u003e2024 B-BBEE threshold increases affect eligibility\u003c\/li\u003e\n\u003cli\u003eCompliance across ownership, management, procurement required\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLabor Relations and Trade Unions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe political influence of labor unions in South Africa strongly affects manufacturing; COSATU and NUMSA-backed actions contributed to 2023 sectoral disruptions, with strike days rising 12% year-on-year and wage settlements averaging 6–8% in 2024.\u003c\/p\u003e\n\u003cp\u003eWage negotiations and potential industrial action reflect labor law reforms and broader politics; in 2024, manufacturing lost estimated R9.4 billion to strike-related downtime, making stable labor relations critical for Ascendis Health’s contract manufacturing.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eUnion influence: COSATU\/NUMSA prominent\u003c\/li\u003e\n\u003cli\u003e2024 wage settlements: ~6–8%\u003c\/li\u003e\n\u003cli\u003eStrike impact: R9.4 billion manufacturing loss (2024)\u003c\/li\u003e\n\u003cli\u003ePriority: maintain stable relations to avoid production halts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMargins squeezed by NHI, volatile exports and rising compliance \u0026amp; labor risks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCentralized NHI procurement and tighter public budgets (ZAR 263bn public health spend 2023) compress margins and extend receivables; exports = 28% FY2024 revenue with 12% YoY export volatility; SAHPRA inspections +12% (2024) slow launches; public tenders ~30–40% revenue exposure; 2024 B-BBEE threshold rises and strike losses R9.4bn heighten compliance and labor risks.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2023–2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublic health spend\u003c\/td\u003e\n\u003ctd\u003eZAR 263bn (2023)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eExports share\u003c\/td\u003e\n\u003ctd\u003e28% FY2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eExport volatility\u003c\/td\u003e\n\u003ctd\u003e+12% YoY (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSAHPRA inspections\u003c\/td\u003e\n\u003ctd\u003e+12% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTender exposure\u003c\/td\u003e\n\u003ctd\u003e30–40% revenue\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStrike loss\u003c\/td\u003e\n\u003ctd\u003eR9.4bn (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how external macro-environmental factors uniquely affect Ascendis Health across Political, Economic, Social, Technological, Environmental, and Legal dimensions, with each section backed by relevant data and trends for reliable evaluation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise PESTLE summary of Ascendis Health that highlights external risks and opportunities for quick inclusion in presentations or strategy sessions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCurrency Exchange Rate Volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFluctuations in the ZAR—which fell ~8% vs USD in 2023 and averaged 18.5 ZAR\/USD in 2024—raise import costs for Ascendis Health’s APIs and raw materials sourced globally, squeezing margins if price increases cannot be passed to customers. With ~40–60% of inputs imported for SA operations, sustained ZAR weakness can materially impact gross margins. Active hedging (forwards\/options) and currency invoicing are essential to manage FX exposure.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsumer Purchasing Power Trends\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eInflation in South Africa averaged 5.5% in 2024 and the repo rate sat at 8.25% in Dec 2025, squeezing real wages and disposable income for many households.\u003c\/p\u003e\n\u003cp\u003eHigher living costs have driven a measurable shift toward generics: market share of generics in private-sector prescriptions rose to ~45% in 2024 from ~38% in 2020. \u003c\/p\u003e\n\u003cp\u003eAscendis must expand value-based offerings—generics and lower-cost formulations—while preserving margins through cost optimisation and targeted pricing to serve price-sensitive segments. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare Infrastructure Investment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEconomic growth rates shape healthcare infrastructure investment: global health spending rose to about 10.2% of GDP in 2023 and capital expenditure for hospitals grew ~4.5% y\/y in 2024, expanding demand for Ascendis Health’s devices and pharmaceuticals; IMF forecasts 3.1% global GDP growth in 2025 support continued private\/public funding, while regions facing stagnation — e.g., parts of Europe with 0–1% growth in 2024 — show deferred maintenance and lower procurement volumes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCost of Energy and Logistics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cprising electricity tariffs y in south africa and frequent load-shedding elevate ascendis healths manufacturing distribution costs with energy accounting for a growing share of cogs cold-chain drug storage requires uninterrupted power to avoid product losses. companies face higher logistics as port congestion road transport delays raise lead times inventory carrying costs. investment solar battery systems optimized reduces exposure rising utility bills bottlenecks.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eElectricity tariffs +15% y\/y (2024) increasing operating costs\u003c\/li\u003e\n\u003cli\u003eLoad-shedding risk threatens cold-chain integrity, raising spoilage risk\u003c\/li\u003e\n\u003cli\u003ePort\/logistics delays elevate inventory and distribution expenses\u003c\/li\u003e\n\u003cli\u003eCapex for solar + battery and logistics optimization mitigates risk\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/prising\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Commodity Price Fluctuations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpglobal commodity price swings directly affect ascendis health animal and consumer-product inputs with corn soybean meal up to volatile year-on-year petrochemical feedstocks rising in driving unpredictable cogs pressure.\u003e\n\u003cpstrategic sourcing and multi-year supplier contracts used by ascendis aim to cap input cost exposure the company reported procurement covering of volume through stabilize margins.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eInput cost volatility: corn\/soy ±35% YoY; petrochemicals +12% in 2024\u003c\/li\u003e\n\u003cli\u003eCOGS exposure mitigated via ~60% hedged\/contracted volumes through 2025\u003c\/li\u003e\n\u003cli\u003eUnpredictable prices can compress gross margin if sourcing strategies fail\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pstrategic\u003e\u003c\/pglobal\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eZAR slump, rising costs \u0026amp; tariffs push SA demand to generics; procurement hedged ~60%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZAR weakness (−8% vs USD in 2023; 18.5 ZAR\/USD avg 2024) raises imported input costs; SA inflation 5.5% (2024) and repo 8.25% (Dec 2025) shift demand to generics (private-sector share ~45% in 2024); electricity tariffs +15% (2024) and load-shedding increase manufacturing\/logistics costs; procurement covers ~60% volumes through 2025 to mitigate input volatility.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eZAR\/USD (2024)\u003c\/td\u003e\n\u003ctd\u003e18.5\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInflation (SA 2024)\u003c\/td\u003e\n\u003ctd\u003e5.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRepo (Dec 2025)\u003c\/td\u003e\n\u003ctd\u003e8.25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGenerics share (2024)\u003c\/td\u003e\n\u003ctd\u003e~45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eElec tariffs (2024)\u003c\/td\u003e\n\u003ctd\u003e+15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProcurement hedged\u003c\/td\u003e\n\u003ctd\u003e~60% through 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eAscendis Health PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact Ascendis Health PESTLE Analysis you’ll receive after purchase—fully formatted, professionally structured, and ready to use for strategic decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751691039097,"sku":"ascendishealth-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/ascendishealth-pestle-analysis.png?v=1772234087","url":"https:\/\/growthsharematrix.com\/products\/ascendishealth-pestle-analysis","provider":"Growth Share Matrix","version":"1.0","type":"link"}